Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system.
Level 5 - mechanism / opinion, no new human data
Narrative review and mechanism-based reasoning
PubMed 19549926 · doi:10.1124/pr.109.001321
What was done
This narrative review synthesizes research on the physiological roles of the orexin/hypocretin system, focusing on its regulatory functions across sleep-wake states, energy homeostasis, feeding behavior, and reward circuitry.
What was found
The abstract reports no quantitative data. It describes that orexin deficiency causes narcolepsy in humans, dogs, and rodents, as well as disturbances in energy homeostasis and reward systems. Orexin neurons activate monoaminergic and cholinergic neurons in the hypothalamus and brainstem to maintain consolidated wakefulness, receive inputs from the limbic system, connect reciprocally with the arcuate nucleus, respond to metabolic signals (leptin and glucose), and connect to the dopaminergic reward system in the ventral tegmental area.
Why it matters
The paper highlights orexin as a master integrator linking vigilance states with metabolic cues and reward processing, identifying the pathway as a therapeutic target for sleep disorders, obesity, emotional stress, and addiction.
Limits
The abstract provides no quantitative metrics or systematic review methodology. The synthesis relies heavily on animal models, mechanistic neuroanatomy, and non-systematic literature selection.
Cited by
- supports The orexin (hypocretin) system is involved in hunger regulation and has implications for the treatment of obesity.